What it's for (Indications)
- Quatrefolic (as the glucosamine salt of (6S)-5-methyltetrahydrofolate, or 5-MTHF) is indicated primarily for the dietary management and prevention of folate deficiency.
- Its enhanced bioavailability makes it particularly beneficial for individuals with genetic polymorphisms, such as those affecting the methylenetetrahydrofolate reductase (MTHFR) enzyme, which impair the conversion of synthetic folic acid to its active form.
- Key indications include supplementation during pregnancy to reduce the risk of neural tube defects, management of hyperhomocysteinemia, support for cardiovascular health, and addressing folate-responsive megaloblastic anemia.
- It is also used to support mood regulation and cognitive function, as folate plays a crucial role in neurotransmitter synthesis and methylation processes essential for neurological health.
- The active form bypasses metabolic steps, ensuring efficient utilization in the body for critical cellular functions and DNA synthesis, especially relevant in conditions demanding higher folate requirements or where metabolic conversion is suboptimal.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The appropriate dosage of Quatrefolic (5-MTHF) can vary significantly based on the individual's specific needs, existing folate status, genetic profile, and the particular clinical indication. For general adult supplementation, common dosages typically range from 400 mcg to 1000 mcg (1 mg) of 5-MTHF daily. In pregnancy planning and during pregnancy, dosages often align with recommendations for folic acid, commonly 600 mcg to 800 mcg of Dietary Folate Equivalents (DFEs) daily, but higher doses up to 1000 mcg may be recommended under medical supervision, especially for women with a history of neural tube defects or MTHFR mutations. For therapeutic management of diagnosed folate deficiency or hyperhomocysteinemia, doses may range from 1 mg to 5 mg or more daily, always under the guidance of a healthcare professional. Doses should be adjusted based on laboratory monitoring of folate levels and clinical response to ensure optimal efficacy and safety. It is crucial to consult a healthcare provider to determine the most appropriate dosage regimen. |
Safety & Warnings
Common Side Effects
- Quatrefolic (5-MTHF) is generally very well-tolerated, given its nature as an active and highly bioavailable form of an essential B vitamin.
- Adverse effects are rare, especially at recommended dosages, and serious side effects are exceedingly uncommon.
- When side effects do occur, they are typically mild and transient.
- These may include gastrointestinal disturbances such as nausea, bloating, abdominal discomfort, or mild diarrhea.
- Allergic reactions, though uncommon, could manifest as skin rash, itching, or hives in hypersensitive individuals.
- Very high doses of folate, irrespective of its form, can potentially lead to some central nervous system effects, including irritability, sleep disturbances, or excitement, though this is exceedingly rare with typical supplementation and usually associated with extremely high, unmonitored intake.
- The primary clinical concern with high folate intake, particularly in the absence of proper vitamin B12 assessment, is its potential to mask the hematological symptoms of vitamin B12 deficiency, thereby allowing neurological damage to progress unnoticed.
Serious Warnings
- Black Box Warning: BLACK BOX WARNING: NOT APPLICABLE. Quatrefolic (5-methyltetrahydrofolate) is a dietary supplement ingredient, not a prescription drug that typically carries an FDA-mandated Black Box Warning. However, a significant safety consideration warrants a prominent warning: **SERIOUS WARNINGS: POTENTIAL MASKING OF VITAMIN B12 DEFICIENCY** Quatrefolic (5-methyltetrahydrofolate), while an essential nutrient, carries a critical risk related to its use in individuals with underlying vitamin B12 deficiency. High doses of any form of folate, including Quatrefolic, can ameliorate the megaloblastic anemia associated with vitamin B12 deficiency. This hematological improvement, however, can obscure the progression of irreversible neurological damage that is characteristic of untreated vitamin B12 deficiency. This masking effect can lead to a delay in diagnosis and appropriate treatment for vitamin B12 deficiency, potentially resulting in severe and permanent neurological impairment, including peripheral neuropathy, cognitive decline, and spinal cord degeneration. Therefore, it is imperative that vitamin B12 deficiency be definitively ruled out through appropriate diagnostic testing (e.g., serum B12 levels, methylmalonic acid, homocysteine) prior to initiating high-dose Quatrefolic supplementation, particularly in elderly individuals, vegetarians/vegans, those with malabsorption disorders, or patients with a history suggestive of B12 deficiency. Concurrent and adequate vitamin B12 supplementation is essential if a deficiency is identified and folate supplementation is deemed necessary, to prevent potentially devastating neurological sequelae.
- Patients should exercise caution when taking Quatrefolic (5-MTHF), particularly if they have underlying medical conditions or are concurrently using other medications.
- While generally safe, it is imperative to address the potential for high folate intake to mask vitamin B12 deficiency.
- This is a critical concern, as folate supplementation can resolve the megaloblastic anemia associated with B12 deficiency, but it does not address the progressive neurological damage that can occur if the B12 deficiency remains undiagnosed and untreated.
- Therefore, it is strongly recommended that vitamin B12 status be assessed prior to and periodically during high-dose folate supplementation, especially in at-risk populations.
- Individuals with a history of seizures should consult a healthcare professional, as high doses of folate have been reported to potentially interact with some antiepileptic medications, potentially reducing their efficacy.
- Moreover, folate can interact with other drugs such as methotrexate, impairing its mechanism of action, and certain antibiotics or antacids may affect folate absorption or metabolism.
- Always inform your healthcare provider about all supplements and medications you are taking to prevent potential interactions.
How it Works (Mechanism of Action)
Quatrefolic is the brand name for the glucosamine salt of (6S)-5-methyltetrahydrofolate (5-MTHF), which represents the most biologically active and readily available form of folate. Unlike synthetic folic acid, which requires multiple enzymatic steps (including those catalyzed by the methylenetetrahydrofolate reductase, MTHFR, enzyme) to be converted into 5-MTHF, Quatrefolic bypasses these conversion challenges entirely. Upon absorption, 5-MTHF directly enters the folate metabolic pathway without the need for prior metabolism. Its primary role is as a methyl donor, essential for numerous physiological processes, including the remethylation of homocysteine to methionine. Methionine is subsequently converted to S-adenosylmethionine (SAMe), a universal methyl donor involved in critical biochemical reactions such. These include DNA synthesis and repair, gene expression regulation, neurotransmitter synthesis (e.g., serotonin, dopamine, norepinephrine), and myelin sheath formation. This direct bioavailability ensures optimal folate utilization for cellular replication, erythrocyte maturation, and neural development, making it highly effective for individuals with compromised folate metabolism.